Does the media favor PRCT or CV?

In the previous week, PROCEPT BioRobotics and PROCEPT BioRobotics both had 6 articles in the media. CapsoVision's average media sentiment score of 1.47 beat PROCEPT BioRobotics' score of 0.26 indicating that CapsoVision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral CapsoVision 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, AORT or CV?

Artivion has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Artivion $441.33M 2.83 $9.77M $0.24 107.29 CapsoVision $13.55M 23.56 -$25.32M -$2.34 N/A

Is AORT or CV more profitable?

Artivion has a net margin of 2.55% compared to CapsoVision's net margin of -198.87%. Artivion's return on equity of 7.15% beat CapsoVision's return on equity. Company Net Margins Return on Equity Return on Assets Artivion 2.55% 7.15% 3.63% CapsoVision -198.87% N/A -136.03%

Does the media favor AORT or CV?

In the previous week, CapsoVision had 5 more articles in the media than Artivion. MarketBeat recorded 6 mentions for CapsoVision and 1 mentions for Artivion. CapsoVision's average media sentiment score of 1.47 beat Artivion's score of 0.00 indicating that CapsoVision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CapsoVision 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate AVNS or CV?

CapsoVision has a consensus target price of $8.50, indicating a potential upside of 33.02%. Given CapsoVision's stronger consensus rating and higher probable upside, analysts clearly believe CapsoVision is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 CapsoVision 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media refer more to AVNS or CV?

In the previous week, CapsoVision had 5 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for CapsoVision and 1 mentions for Avanos Medical. CapsoVision's average media sentiment score of 1.47 beat Avanos Medical's score of 1.28 indicating that CapsoVision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CapsoVision 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, CV or CNMD?

CONMED has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CapsoVision $13.55M 23.56 -$25.32M -$2.34 N/A CONMED $1.37B 0.99 $47.06M $1.77 25.42

Does the media favor CV or CNMD?

In the previous week, CONMED had 6 more articles in the media than CapsoVision. MarketBeat recorded 12 mentions for CONMED and 6 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.47 beat CONMED's score of 0.23 indicating that CapsoVision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CapsoVision 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor DRTS or CV?

In the previous week, CapsoVision had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for CapsoVision and 5 mentions for Alpha Tau Medical. CapsoVision's average media sentiment score of 1.47 beat Alpha Tau Medical's score of 0.50 indicating that CapsoVision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Tau Medical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CapsoVision 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CapsoVision (CV) Competitors

$6.39 +0.06 (+0.95%)

Closing price 04:00 PM Eastern

Extended Trading

$6.39 0.00 (0.00%)

As of 05:24 PM Eastern

Compare

CV vs. PRCT, AORT, AVNS, CNMD, and DRTS

Should you buy CapsoVision stock or one of its competitors? MarketBeat compares CapsoVision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CapsoVision include PROCEPT BioRobotics (PRCT), Artivion (AORT), Avanos Medical (AVNS), CONMED (CNMD), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.

How does CapsoVision compare to PROCEPT BioRobotics?

PROCEPT BioRobotics (NASDAQ:PRCT) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, PROCEPT BioRobotics and PROCEPT BioRobotics both had 6 articles in the media. CapsoVision's average media sentiment score of 1.47 beat PROCEPT BioRobotics' score of 0.26 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
CapsoVision	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PROCEPT BioRobotics presently has a consensus target price of $37.27, indicating a potential upside of 94.13%. CapsoVision has a consensus target price of $8.50, indicating a potential upside of 33.02%. Given PROCEPT BioRobotics' higher possible upside, research analysts plainly believe PROCEPT BioRobotics is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 4.0% of PROCEPT BioRobotics shares are held by insiders. Comparatively, 2.3% of CapsoVision shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

PROCEPT BioRobotics has a net margin of -31.82% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-31.82%	-27.70%	-20.29%
CapsoVision	-198.87%	N/A	-136.03%

CapsoVision has lower revenue, but higher earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.55	-$95.57M	-$1.82	N/A
CapsoVision	$13.55M	23.56	-$25.32M	-$2.34	N/A

Summary

PROCEPT BioRobotics beats CapsoVision on 8 of the 14 factors compared between the two stocks.

How does CapsoVision compare to Artivion?

Artivion (NYSE:AORT) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

Artivion presently has a consensus target price of $44.17, indicating a potential upside of 71.52%. CapsoVision has a consensus target price of $8.50, indicating a potential upside of 33.02%. Given Artivion's stronger consensus rating and higher possible upside, research analysts plainly believe Artivion is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Artivion has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.83	$9.77M	$0.24	107.29
CapsoVision	$13.55M	23.56	-$25.32M	-$2.34	N/A

Artivion has a net margin of 2.55% compared to CapsoVision's net margin of -198.87%. Artivion's return on equity of 7.15% beat CapsoVision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
CapsoVision	-198.87%	N/A	-136.03%

86.4% of Artivion shares are held by institutional investors. 6.3% of Artivion shares are held by insiders. Comparatively, 2.3% of CapsoVision shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, CapsoVision had 5 more articles in the media than Artivion. MarketBeat recorded 6 mentions for CapsoVision and 1 mentions for Artivion. CapsoVision's average media sentiment score of 1.47 beat Artivion's score of 0.00 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CapsoVision	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Artivion beats CapsoVision on 12 of the 16 factors compared between the two stocks.

How does CapsoVision compare to Avanos Medical?

Avanos Medical (NYSE:AVNS) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

In the previous week, CapsoVision had 5 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for CapsoVision and 1 mentions for Avanos Medical. CapsoVision's average media sentiment score of 1.47 beat Avanos Medical's score of 1.28 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CapsoVision	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.2% of Avanos Medical shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 2.3% of CapsoVision shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CapsoVision has a consensus target price of $8.50, indicating a potential upside of 33.02%. Given CapsoVision's stronger consensus rating and higher probable upside, analysts clearly believe CapsoVision is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

CapsoVision has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
CapsoVision	$13.55M	23.56	-$25.32M	-$2.34	N/A

Avanos Medical has a net margin of -10.39% compared to CapsoVision's net margin of -198.87%. Avanos Medical's return on equity of 5.39% beat CapsoVision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
CapsoVision	-198.87%	N/A	-136.03%

Summary

CapsoVision beats Avanos Medical on 9 of the 16 factors compared between the two stocks.

How does CapsoVision compare to CONMED?

CapsoVision (NASDAQ:CV) and CONMED (NYSE:CNMD) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

CapsoVision currently has a consensus target price of $8.50, suggesting a potential upside of 33.02%. CONMED has a consensus target price of $38.80, suggesting a potential downside of 13.76%. Given CapsoVision's stronger consensus rating and higher probable upside, research analysts plainly believe CapsoVision is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

In the previous week, CONMED had 6 more articles in the media than CapsoVision. MarketBeat recorded 12 mentions for CONMED and 6 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.47 beat CONMED's score of 0.23 indicating that CapsoVision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CapsoVision	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

CONMED has a net margin of 4.00% compared to CapsoVision's net margin of -198.87%. CONMED's return on equity of 13.84% beat CapsoVision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
CONMED	4.00%	13.84%	6.05%

CONMED has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	23.56	-$25.32M	-$2.34	N/A
CONMED	$1.37B	0.99	$47.06M	$1.77	25.42

Summary

CONMED beats CapsoVision on 8 of the 14 factors compared between the two stocks.

How does CapsoVision compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTS) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

In the previous week, CapsoVision had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for CapsoVision and 5 mentions for Alpha Tau Medical. CapsoVision's average media sentiment score of 1.47 beat Alpha Tau Medical's score of 0.50 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CapsoVision	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 2.3% of CapsoVision shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Alpha Tau Medical has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-73.23%	-52.90%
CapsoVision	-198.87%	N/A	-136.03%

CapsoVision has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A
CapsoVision	$13.55M	23.56	-$25.32M	-$2.34	N/A

Alpha Tau Medical presently has a consensus target price of $12.60, indicating a potential upside of 6.06%. CapsoVision has a consensus target price of $8.50, indicating a potential upside of 33.02%. Given CapsoVision's stronger consensus rating and higher probable upside, analysts clearly believe CapsoVision is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

CapsoVision beats Alpha Tau Medical on 9 of the 15 factors compared between the two stocks.

Get CapsoVision News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CV vs. The Competition

Export

Metric	CapsoVision	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$316.27M	$3.15B	$5.09B	$12.67B
Dividend Yield	N/A	N/A	34.29%	8.87%
P/E Ratio	-2.73	22.68	23.66	24.05
Price / Sales	23.56	243.45	132.64	89.73
Price / Cash	N/A	8.96	164.96	59.89
Price / Book	22.82	5.87	11.84	6.23
Net Income	-$25.32M	$23.43M	$121.47M	$331.94M
7 Day Performance	10.75%	-4.09%	-2.16%	-1.93%
1 Month Performance	-3.62%	-7.26%	-2.97%	-0.97%
1 Year Performance	34.24%	-24.10%	10.66%	18.24%

CapsoVision Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CV CapsoVision	2.9701 of 5 stars	$6.39 +0.9%	$8.50 +33.0%	+37.9%	$316.27M	$13.55M	N/A	90	Positive News
PRCT PROCEPT BioRobotics	3.1936 of 5 stars	$21.22 +1.6%	$37.27 +75.6%	-67.0%	$1.19B	$308.05M	N/A	430
AORT Artivion	3.702 of 5 stars	$24.02 -0.3%	$44.17 +83.9%	-22.2%	$1.17B	$441.33M	37.06	1,800
AVNS Avanos Medical	0.7643 of 5 stars	$24.95 +0.1%	N/A	+116.6%	$1.17B	$701.20M	27.70	2,287
CNMD CONMED	1.6758 of 5 stars	$42.47 +10.4%	$38.80 -8.6%	-12.0%	$1.16B	$1.37B	8.46	3,900	Analyst Downgrade Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CV) was last updated on 7/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CapsoVision (CV) Competitors

CV vs. PRCT, AORT, AVNS, CNMD, and DRTS

How does CapsoVision compare to PROCEPT BioRobotics?

Summary

How does CapsoVision compare to Artivion?

Summary

How does CapsoVision compare to Avanos Medical?

Summary

How does CapsoVision compare to CONMED?

Summary

How does CapsoVision compare to Alpha Tau Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CV vs. The Competition

CapsoVision Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CapsoVision (CV) Competitors

CV vs. PRCT, AORT, AVNS, CNMD, and DRTS

How does CapsoVision compare to PROCEPT BioRobotics?

Does the media favor PRCT or CV?

Do analysts recommend PRCT or CV?

Do insiders and institutionals believe in PRCT or CV?

Is PRCT or CV more profitable?

Which has stronger valuation & earnings, PRCT or CV?

Summary

How does CapsoVision compare to Artivion?

Do analysts recommend AORT or CV?

Which has stronger valuation & earnings, AORT or CV?

Is AORT or CV more profitable?

Do insiders and institutionals believe in AORT or CV?

Does the media favor AORT or CV?

Summary

How does CapsoVision compare to Avanos Medical?

Does the media refer more to AVNS or CV?

Do insiders and institutionals believe in AVNS or CV?

Do analysts rate AVNS or CV?

Which has higher valuation & earnings, AVNS or CV?

Is AVNS or CV more profitable?

Summary

How does CapsoVision compare to CONMED?

Do analysts recommend CV or CNMD?

Does the media favor CV or CNMD?

Is CV or CNMD more profitable?

Which has higher earnings & valuation, CV or CNMD?

Summary

How does CapsoVision compare to Alpha Tau Medical?

Does the media favor DRTS or CV?

Do institutionals & insiders believe in DRTS or CV?

Is DRTS or CV more profitable?

Which has higher earnings & valuation, DRTS or CV?

Do analysts rate DRTS or CV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CV vs. The Competition

CapsoVision Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools